CVE-2026-21997
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core).
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.20%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
- CVSS 3.1
- 8.5 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
- EPSS
- 0.20% probability · 10th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-284
- Affected
- oracle/life sciences empirica signal
- Source
- secalert_us@oracle.com
References
- https://www.oracle.com/security-alerts/cpuapr2026.htmlVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.